EGFR and lung cancer: The finding that the loss of DHHC20 and EGFR palmitoylation in MDA-MB-231 breast cancer cells and SW1573 lung cancer cells extended the duration of EGFR signalling in response to EGF highlights a possible connection between EGFR palmitoylation and EGFR signalling kinetics [21].